Company intelligence / Profile preview

The Valence Group

Ownership: Private
Development stage: Other

Overview

The Valence Group appears to be a corporate finance and mergers-and-acquisitions advisory firm rather than a biotech, pharmaceutical, or healthcare operating company. Publicly accessible information indicates it provides strategic and financial advisory services, including transaction support, to companies and investors. Based on the available evidence, it does not appear to develop therapeutics, own a drug pipeline, or operate as a life sciences platform company. As a result, biotech-specific fields such as modalities, targets, indications, and clinical stage are not applicable.

Industry: Consulting

Beyond the preview

Go deeper on The Valence Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on The Valence Group.

Explore the full profile